(Q51080130)

29 March 2018

title

A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. (English)

1 reference

29 March 2018

main subject

hepatocellular carcinoma

1 reference

Jing Xu

1

1 reference

29 March 2018

Zhong-Yang Shen

2

1 reference

29 March 2018

Xin-Guo Chen

3

1 reference

29 March 2018

Qing Zhang

4

1 reference

29 March 2018

Hui-Jie Bian

5

1 reference

29 March 2018

Ping Zhu

6

1 reference

29 March 2018

Hui-Yun Xu

7

1 reference

29 March 2018

Fei Song

8

1 reference

29 March 2018

Xiang-Min Yang

9

1 reference

29 March 2018

Li Mi

10

1 reference

29 March 2018

Qing-Chuan Zhao

11

1 reference

29 March 2018

Rong Tian

12

1 reference

29 March 2018

Qiang Feng

13

1 reference

29 March 2018

Si-He Zhang

14

1 reference

29 March 2018

Yu Li

15

1 reference

29 March 2018

Jian-Li Jiang

16

1 reference

29 March 2018

Ling Li

17

1 reference

29 March 2018

Xiao-Ling Yu

18

1 reference

29 March 2018

Zheng Zhang

19

1 reference

29 March 2018

Zhi-Nan Chen

20

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

29 March 2018

published in

Hepatology

1 reference

29 March 2018

volume

45

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

269-276

1 reference

29 March 2018

Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.

cites work

1 reference

CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.

21 January 2018

1 reference

A decade's studies on metastasis of hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Tumor marker for metastasis: searching for an abnormal needle in a haystack

1 reference

7 January 2021

Expression profiling in hepatocellular carcinoma with intrahepatic metastasis: identification of high-mobility group I(Y) protein as a molecular marker of hepatocellular carcinoma metastasis

1 reference

7 January 2021

Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma

1 reference

7 January 2021

Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?

1 reference

7 January 2021

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

7 January 2021

The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991.

1 reference

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

7 January 2021

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

1 reference

7 January 2021

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

1 reference

7 January 2021

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

7 January 2021

Biodistribution and localization of iodine-131-labeled metuximab in patients with hepatocellular carcinoma

1 reference

7 January 2021

Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function

1 reference

7 January 2021

Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma

1 reference

7 January 2021

The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells

1 reference

7 January 2021

HAb18G/CD147 enhances the secretion of matrix metalloproteinases (MMP) via cGMP/NO-sensitive capacitative calcium entry (CCE) and accordingly attenuates adhesion ability of fibroblasts.

1 reference

7 January 2021

HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains

1 reference

7 January 2021

Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma

1 reference

7 January 2021

The quandary over liver transplantation for hepatocellular carcinoma: the greater sin?

1 reference

7 January 2021

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

1 reference

7 January 2021

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization

1 reference

7 January 2021

Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?

1 reference

7 January 2021

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

7 January 2021

Hepatic resection versus transplantation for hepatocellular carcinoma

1 reference

7 January 2021

The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21465

1 reference

29 March 2018

1 reference

29 March 2018